3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
6
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Small Cell Lung Carcinoma
4
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Unresectable Hepatocellular Carcinoma
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcopenia
1
Recurrent Squamous Cell Lung Carcinoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Oropharyngeal Neoplasms
1
Non-Small Cell Lung Cancer NSCLC
1
Neoplasms
1
Melanoma
1
Kidney Neoplasms
1
Hepatobiliary Cancers
1
Head and Neck Neoplasms
1
Deglutition Disorders
1
Interventions
Surveys and Questionnaires
7
Radiotherapy, Intensity-Modulated
2
Liquid Biopsy
2
Immunohistochemistry
2
Counseling
2
Blood Specimen Collection
2
Biopsy
2
pembrolizumab
1
durvalumab
1
Watchful Waiting
1
Therapeutics
1
Surgical Procedures, Operative
1
Radiotherapy, Adjuvant
1
Radiotherapy
1
Radiation
1
Psychiatric Rehabilitation
1
Physical Examination
1
Palliative Care
1
Observation
1
Nivolumab
1
Neoadjuvant Therapy
1
Mental Status and Dementia Tests
1
Interviews as Topic
1
Immunotherapy
1
Immune Checkpoint Inhibitors
1
Gene Expression Profiling
1
Exercise Test
1
Drug Therapy
1
Diagnosis, Oral
1
Comparative Genomic Hybridization
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Oropharyngeal Neoplasms
×
durvalumab
×
Clear all
NCT04359199
2023-02-10
QUASAR
University of California, San Diego
Unknown
42 enrolled